邹陆曦

时间:2023-08-23   点击数:[]

 

个人简介:

邹陆曦,男,副教授,高级工程师,硕士研究生导师,研究方向:智慧医疗与数字健康。毕业于浙江大学,管理学博士,江苏省双创博士(世界名校类)。曾赴加州大学洛杉矶分校(UCLA)学习,获得博士研究生“国家奖学金”和“浙江省优秀博士毕业生”称号。工作方面:曾就职于世界五百强,拥有企业实战经验。学术方面:获“江苏省医学引进新技术二等奖”1项及“徐州市医学新技术引进一等奖”1项。曾主持江苏省科技计划专项资金(创新支撑计划软科学研究),徐州市重点研发科技计划(社会发展)项目,江苏省高校哲学社会科学研究一般项目;参与“国家自然科学基金”、“江苏省自然科学基金”、“徐州市科技计划”等多个科研项目,兼任多家SCI杂志的审稿人,以第一和通讯作者发表SCI论文20余篇,中文核心期刊论文多篇,授权专利4项。

主要讲授课程:

主要讲授本科生《信息经济学》《微观经济学》《宏观经济学》《医学大数据》《档案信息管理》《研究设计与写作》等课程;研究生《公共经济学》《公共信息资源管理》课程。

代表性研究项目:

1.江苏省科技计划专项资金(创新支撑计划软科学研究),BR2022011,江苏省人工智能与医疗健康融合发展研究,2022-2023,5万,主持

2.徐州市重点研发计划(社会发展)项目, KC20182,基于人工智能的糖尿病肾病预测及治疗成本效果研究,2020/08-2022/07,10万, 主持。

3.江苏高校哲学社会科学研究一般项目,2021SJA1096, 金融创新之互联网金融平台实证研究,2021/07-2023/06,1万, 主持。

代表性研究成果:

1.Zou Lu-Xi, Sun Ling*, Hua Rui-Xue, Wu Yu, Sun Linlin, Chen Ting. Degradation of Ubiquitin-Editing Enzyme A20 following Autophagy Activation Promotes RNF168 Nuclear Translocation and NF-kappaB Activation in Lupus Nephritis[J]. J Innate Immun, 2023, 15(1): 428-441.

2.Sun Ling, Hua Rui-Xue, Wu Yu, Zou Lu-Xi*. Effect of different hemodialysis modalities on hepcidin clearance in patients undergoing maintenance hemodialysis[J]. Semin Dial, 2023, 36(3): 240-246.

3.Sun Ling, Wu Yu, Hua Rui-Xue, Zou Lu-Xi*. Prediction models for risk of diabetic kidney disease in Chinese patients with type 2 diabetes mellitus[J]. Renal Failure, 2022, 44(1): 1454-1461.

4.Zou Lu-Xi, Sun Ling*, Nicholas S. B.*, Lu Yan, K Satyesh Sinha, Hua Ruixue. Comparison of bias and accuracy using cystatin C and creatinine in CKD-EPI equations for GFR estimation[J]. European Journal of Internal Medicine, 2020, 80(20): 29-34.

5.Zou Lu-Xi, Sun Ling*. Analysis of hemorrhagic fever with renal syndrome using wavelet tools in mainland China, 2004-2019[J]. Frontiers in Public Health, 2020, 8: 571984.

6.Zou Lu-Xi, Sun Ling*. Visualization analysis of health informatics research from 2001 to 2018[J]. Current Science, 2020, 118(5): 714-721.

7.Sun Ling*, Zou Lu-Xi*, Han Yu-Chen, Zhu Dong-Dong, Chen Ting, Wang Jie. Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice[J]. Clinical and Experimental Nephrology, 2020, 24(2): 107-118.

8.Zou Lu-Xi, Sun Ling*, Deng Na, Sun Lei, Han Yu-Chen. Effect of dialysate glucose concentration on hepcidin clearance in maintenance hemodialysis patients[J]. IJKD, 2019, 13(2): 113-119.

9.Sun Ling*, Zou Lu-Xi, Lu Yan, Deng Na, Wang Hui-Xin. Effect of serum hepcidin on predicting mortality in hemodialysis patients[J]. IRCMJ, 2019, 21(3): e87091.

10.Sun Ling*, Zou Lu-Xi, Han Yu-Chen, Wu Ling, Chen Ting, Zhu Dong-Dong, Hu Po. A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1[J]. Journal of Cellular Physiology, 2019: 16191-16204.

11.Liu Qigui, Zou Luxi, Yang Xiaolin, Tang Jinghua*. Survival or die: a survival analysis on peer‐to‐peer lending platforms in China[J]. Accounting & Finance, 2019, 59(S2): 2105-2131.

12.Zou Lu-Xi, Sun Ling*. Forecast post-dialysis blood pressure in hemodialysis patients with intradialytic hypertension[J]. Clinical and Experimental Hypertension, 2018, 41(6): 571-576.

13.Sun Ling*, Zou Lu-Xi. Spatiotemporal analysis and forecasting model of hemorrhagic fever with renal syndrome in mainland China[J]. Epidemiology and infection, 2018, 146(13): 1680-1688.

14.Zou Lu-Xi, Chen Mao-Jie, Sun Ling*. Haemorrhagic fever with renal syndrome: literature review and distribution analysis in China[J]. International Journal of Infectious Diseases, 2016, 43(3): 95-100.

15.Sun Ling, Zou Lu-Xi, Han Yu-Chen, Huang Han-Ming, Tan Zhao-Ming, Gao Min., Ma Kun-Ling, Liu Hong, Liu Bi-Cheng*. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025[J]. BMC Nephrology, 2016, 17(1): 60.

获奖成果:

江苏省医学引进新技术奖(科研获奖),江苏省卫生健康委员会,二等奖,2020-11-09

徐州市医学新技术引进(科研获奖),徐州市卫生健康委员会,一等奖2019-12-30

徐州市自然科学优秀术论文(个人获奖)徐州市人民政府,三等奖,2020-12-01

上一条:沈良

下一条:宋小康